Jill Lacy, MD

Professor of Medicine (Medical Oncology)

Clinical Interests

  • Hodgkin Disease
  • Lymphoma
  • Medical Oncology

Patient Care

Accepts new patients? Yes
Patient Type: Adult
Referrals: From patients or physicians

Patient Care Organizations

Cancer Center, Yale: Brain Tumor Center | Gastrointestinal Cancer Program | Sarcoma Oncology Program

Medical Oncology

Yale Medical Group

Board Certifications

  • Medical Oncology AB of Internal Medicine (1991)

Clinical Trials

Conditions Study Title
Pancreas Phase II Study of Peri-Operative Modified Folfirinox in Localized Pancreatic Cancer
Pancreas nab-paclitaxel (Abraxane) plus Gemcitabine in subjects with locally Advanced pancreatic cancer (LAPC): an International, open-label, multi-center, Phase 2 study (LAPACT)
Other Digestive Organ, Stomach A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Capecitabine and Cisplatin With or Without Ramucirumab as First-line Therapy in Patients With Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (RAINFALL)
Pancreas A phase 3, multicenter, open-label, randomized study of nab-Paclitaxel plus gemcitabine versus gemcitabine alone as adjuvant therapy in subjects with surgically resected pancreatic adenocarcinoma

Edit this profile

Contact Info

Jill Lacy, MD
Patient Care Locations
Yale Gastrointestinal Cancers ProgramSmilow Cancer Hospital at Yale - New Haven
35 Park Street, Ste 8th Floor Multispecialty Care Center

New Haven, CT 06511
Yale Brain Tumor ProgramSmilow Cancer Hospital at Yale - New Haven
35 Park Street, Ste 8th Floor Multispecialty Care Center

New Haven, CT 06511
Office Location
Fitkin Memorial Pavilion
789 Howard Avenue, Ste 118

New Haven, CT 06519
Mailing Address
Yale Cancer CenterPO Box 208028
333 Cedar Street, TMP 3

New Haven, CT 06520-8028